Brian J. North is an Assistant Professor in the Biomedical Sciences Department. After receiving his B.A. from Gustavus Adolphus College, he completed his Ph.D. from the University of California San Francisco with Dr. Eric Verdin. He then went on to his postdoctoral fellowship at Harvard Medical School with Dr. David Sinclair, and subsequently was a Research Assistant Professor at Beth Israel Deaconess Medical Center where he worked closely with the lab of Dr. Wenyi Wei. His main research focus is to understand the molecular and cellular pathways involved in regulating the process of aging, and how changes in these pathways contribute to the development of age-related diseases, with a primary interest in tumorigenesis.
The North lab studies the interrelationship between aging and cancer. We are particularly interested in the the role of the ubiquitin-proteasome system in targeting tumor suppressors and oncogenes in an age-dependent manner.
Cancer Research Area(s)
Colon Cancer
Skin Cancer
Age Related Cancer Mechanisms
Research Focus
Molecular basis for aging and its impact on age-related disease susceptibility; Understanding the roles of E3 ubiquitin ligases in tumorigenesis; Regulation and function of NAD+-dependent deacetylases
Nature Cell Biology Gao, Y, Acetylation-dependent regulation of PD-L1 nuclear translocation dictates the efficacy of anti-PD-1 immunotherapy 22, p. 1064-1075 2020
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer Ji Cheng, Jianping Guo, Brian J. North, Bin Wang, Chun-Ping Cui, Hongsheng Li, Kaixiong Tao, Lingqiang Zhang and Wenyi Wei. Functional analysis of deubiquitylating enzymes in tumorigenesis and development 1872, p. 188-312 2019
Molecular Oncology Ying Ma, Danrui Cui, Xiufang Xiong, Hiroyuki Inuzuka, Wenyi Wei, Yi Sun, Brian J. North,# and Yongchao Zhao#. SCFβ-TrCP ubiquitinates CHK1 in an AMPK-dependent manner in response to glucose deprivation 13, p. 307-321 2019
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer Ji Cheng, Jianping Guo, Brian J. North, Kaixiong Tao, Pengbo Zhou, and Wenyi Wei. The emerging role for Cullin 4 family of E3 ligases in tumorigenesis 1871, p. 138-159 2019
Aging Cell Ji Cheng, Brian J. North, Tao Zhang, Xiangpeng Dai, Kaixiong Tao, Jianping Guo, and Wenyi Wei. The Emerging Roles of Protein Homeostasis Governing Pathways in Alzheimer's Disease 17(5), p. e12801 2018
Protein & Cell Yanpeng Ci, Xiaoning Li, Maorong Chen, Jiateng Zhong, Brian J. North, Hiroyuki Inuzuka, Xi He, Yu Li, Jianping Guo, and Xiangpeng Dai. SCFβ-TRCP E3 ubiquitin ligase targets the tumor suppressor ZNRF3 for ubiquitination and degradation 9, p. 879-889 2018
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer Ji Cheng, Jianping Guo, Zhiwei Wang, Brian J. North, Kaixiong Tao, Xiangpeng Dai, and Wenyi Wei. Functional analysis of Cullin 3 E3 ligases in tumorigenesis 1869, p. 11-28 2018
Biochimica et Biophysica Acta Jianping Guo, Ji Cheng, Brian J. North, and Wenyi Wei. Functional analysis of major cancer-related signaling pathways in Alzheimer’s disease etiology 1868, p. 341-358 2017
Oncotarget Yuyong Tan, Yanpeng Ci, Xiangpeng Dai, Wenjian Gan, Fei Wu, Jianping Guo, Deliang Liu, Brian J. North#, Jirong Huo#, and Jinfang Zhang#. Cullin 3SPOP ubiquitin E3 ligase promotes the poly-ubiquitination and degradation of HDAC6 8, p. 47890-47901 2017
Nature Bin Wang, Zuliang Jie, Donghyun Joo, Alban Ordureau, Pengda Liu, Jianping Guo, Wenjian Gan, Jinfang Zhang, Xiangpeng Dai, Brian J. North, Yuhan Chen, Xuhong Cheng, Xiuwu Bian, Lingqiang Zhang, J. Wade Harper, Shao-Cong Sun, and Wenyi Wei. TRAF2 and OTUD7B govern a ubiquitin-dependent switch that regulates mTORC2 signalling 545, p. 365-369 2017
PLoS One Brian J. North, Ingrid Almeciga-Pinto, David Tamang, Min Yang, Simon S. Jones, and Steven N. Quayle. Enhancement of pomalidomide anti-tumor response with ACY-241, a selective HDAC6 inhibitor 12, p. e0173507 2017
Science Signaling Naoe Taira Nihira, Kohei Ogura, Kouhei Shimizu, Brian J. North, Jinfang Zhang, Daming Gao, Hiroyuki Inuzuka, and Wenyi Wei. Acetylation-dependent regulation of Mdm2 oncogenic function 10, 466, p. eaai8026 2017
Science Signaling Kouhei Shimizu, Hidefumi Fukushima, Kohei Ogura, Evan C. Lien, Naoe Taira Nihira, Jinfang Zhang, Brian J. North, Ailan Guo, Katsuyuki Nagashima, Tadashi Nakagawa, Seria Hoshikawa, Asami Watahiki, Koji Okabe, Aya Yamada, Alex Toker, John M. Asara, Satoshi Fukumoto, Keiichi I. Nakayama, Keiko Nakayama, Hiroyuki Inuzuka, and Wenyi Wei. The SCFbeta-TRCP E3 ubiquitin ligase complex targets Lipin1 for ubiquitination and degradation to promote hepatic lipogenesis. 10, 460, p. eaah4117 2017
Oncotarget Li X,, Li X, Dai X, Wan L, Inuzuka H, Sun L, North BJ. Smurf1 regulation of DAB2IP controls cell proliferation and migration. Oncotarget. 2016 May 3;7(18):26057-69. doi: 10.18632/oncotarget.8424. PMID: 27036023; PMCID: PMC5041964. 2016
The Embo Journal North BJ, , North BJ, Rosenberg MA, Jeganathan KB, Hafner AV, Michan S, Dai J, Baker DJ, Cen Y, Wu LE, Sauve AA, van Deursen JM, Rosenzweig A, Sinclair DA. SIRT2 induces the checkpoint kinase BubR1 to increase lifespan. EMBO J. 2014 Jul 1;33(13):1438-53. doi: 10.15252/embj.201386907. Epub 2014 May 12. PMID: 24825348; PMCID: PMC4194088. 2014
Neoplasia Bonezzi K,, Bonezzi K, Belotti D, North BJ, Ghilardi C, Borsotti P, Resovi A, Ubezio P, Riva A, Giavazzi R, Verdin E, Taraboletti G. Inhibition of SIRT2 potentiates the anti-motility activity of taxanes: implications for antineoplastic combination therapies. Neoplasia. 2012 Sep;14(9):846-54. doi: 10.1593/neo.12728. PMID: 23019416; PMCID: PMC3459280. 2012
Proc Natl Acad Sci U S A Beirowski B,, Beirowski B, Gustin J, Armour SM, Yamamoto H, Viader A, North BJ, Michán S, Baloh RH, Golden JP, Schmidt RE, Sinclair DA, Auwerx J, Milbrandt J. Sir-two-homolog 2 (Sirt2) modulates peripheral myelination through polarity protein Par-3/atypical protein kinase C (aPKC) signaling. Proc Natl Acad Sci U S A. 2011 Oct 25;108(43):E952-61. doi: 10.1073/pnas.1104969108. Epub 2011 Sep 26. PMID: 21949390; PMCID: PMC3203793. 2011
J Biol Chem North BJ,, North BJ, Verdin E. Mitotic regulation of SIRT2 by cyclin-dependent kinase 1-dependent phosphorylation. J Biol Chem. 2007 Jul 6;282(27):19546-55. doi: 10.1074/jbc.M702990200. Epub 2007 May 8. PMID: 17488717. 2007
PLoS Biology Pagans S, , Pagans S, Pedal A, North BJ, Kaehlcke K, Marshall BL, Dorr A, Hetzer-Egger C, Henklein P, Frye R, McBurney MW, Hruby H, Jung M, Verdin E, Ott M. SIRT1 regulates HIV transcription via Tat deacetylation. PLoS Biol. 2005 Feb;3(2):e41. doi: 10.1371/journal.pbio.0030041. Epub 2005 Feb 8. PMID: 15719057; PMCID: PMC546329. 2005
Molecular Cell Kouhei Shimizu, Brian J. North, Satoshi Fukumoto, Wenyi Wei, Hiroyuki Inuzuka. Interplay between protein acetylation and ubiquitination controls MCL1 protein stability
Nature Yang Gao, Naoe T. Nihira, Xia Bu, Jinfang Zhang, Chen Chu, Yizeng Fan, Leina Ma,Aleksandra Kolodziejczyk, Jing Liu, Dong Wang, Xiaoming Dai, Huadong Liu, Masaya Ono, Hiroyuki Inuzuka, Brian J. North, Yu-Han Huang, Samanta Sharma, Geng Yan, Lei Li,Yoshio Miki, Piotr Sicinski, Gordon J. Freeman, Wenyi Wei. Acetylation-dependent regulation of PD-L1 nuclear translocation dictates the efficacy of anti-PD-1 immunotherapyAcetylation-dependent regulation of PD-L1 nuclear translocation dictates the efficacy of anti-PD-1 immunotherapy
Jianfeng Shu, Haibo Li, Brian J. North, and Ying Ma. Regulation of Topoisomerase II stability and activity by ubiquitination and SUMOylation:Clinical implications for cancer chemotherapy
National Institutes of Health K01 Career Development Award National Institutes of Health K01 Career Development Award (NIH/NIA AG052627)
Gustavus Adolphus College Decade Award Gustavus Adolphus College Decade Award
BIDMC/National Institutes of Aging T32 Translational Research in Aging Award BIDMC/National Institutes of Aging T32 Translational Research in Aging Award